SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-028016
Filing Date
2024-12-02
Accepted
2024-12-02 19:02:36
Documents
2
Period of Report
2024-11-20

Document Format Files

Seq Description Document Type Size
1 form3-12032024_121232.html 3  
1 form3-12032024_121232.xml 3 16205
2 ex24-12032024_121233.htm EX-24 4007
  Complete submission text file 0001415889-24-028016.txt   21749
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Issuer) CIK: 0001601830 (see all company filings)

IRS No.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 44 WALL STREET 12TH FLOOR NEW YORK NY 10005
Business Address
Taylor Ben R (Reporting) CIK: 0001712276 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40323 | Film No.: 241520514